Skip to content

Potentiam Biosciences

Therapeutic target discovery with AI

Raised to date

$250K

across 1 Form D filing

Investors
1
Last filed
Nov 16, 2026

About

Potentiam Biosciences is a biotechnology company that discovers and develops novel therapeutic targets using AI-driven platforms to identify genetic insights. It was founded by Nobel laureate Bruce Beutler with Peppi Prasit and Xinzhu Wang and is based in Irving, Texas. Its full website is not yet live.

Founded by Nobel Prize-winning immunologist Bruce Beutler, combining genetic discovery with AI platforms.

Funding

  • Security to be acquiredFiled Nov 16, 2026Form D
    $250K/ no target

Product

Therapeutic target discovery platform

Drug discovery

AI-powered platforms for identifying genetic insights that point to novel therapeutic targets for drug development.

  • AI-driven analysis of genetic data
  • Novel therapeutic target identification

Built for

Drug development, as a company discovering and developing its own therapeutic targets

People on file